Blood cell research could pave way for new immune treatments
NCT ID NCT04838171
First seen Jan 21, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study looks at white blood cells from healthy volunteers and people with autoimmune diseases, inflammation, or liver transplant rejection. The goal is to understand these cells better so scientists can create new engineered regulatory T cell (Treg) therapies. The study involves about 10 participants and focuses on counting and measuring different types of white blood cells and how they work.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Quell Investigator Site 01
RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.